GoResp Digihaler (previously Budesonide/Formoterol Teva Pharma B.V.)

Budesonide/Formoterol Teva Pharma B.V. is a medicine used for the treatment of asthma in adults for whom a combination product is considered appropriate. It can be used in patients: - whose disease is not adequately controlled by treatment with other asthma medicines called corticosteroids and ‘short-acting beta-2 agonists’ taken by inhalation; - whose disease is adequately controlled by treatment with corticosteroids and ‘long-acting beta-2 agonists’ taken by inhalation. Budesonide/Formoterol Teva Pharma B.V. is also used to relieve the symptoms of severe chronic obstructive pulmonary disease (COPD) in adults who have had exacerbations (flare–ups) of the disease in the past despite regular treatment. COPD is a long-term disease in which the airways and air sacs inside the lungs become damaged or blocked, leading to difficulty in breathing. Budesonide/Formoterol Teva Pharma B.V. is a ‘hybrid medicine’. This means that it is similar to a ‘reference medicine’ containing the same active substances, but Budesonide/Formoterol Teva Pharma B.V. is given using a different inhaler. The reference medicine for Budesonide/Formoterol Teva Pharma B.V. is Symbicort Turbohaler. Budesonide/Formoterol Teva Pharma B.V. contains the active substances budesonide and formoterol.